Valuation
MRKMerck
StockNYSEVereinigte StaatenHealth careEU retail: availableOwner holds
8/10
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | MRK | Sector median | vs median |
|---|---|---|---|
| P/E | 114,6 | 28,8 · n=114 | 298 % above |
| P/B | 8,7 | 3,0 · n=196 | 188 % above |
| P/S | 5,5 | 3,7 · n=202 | 47 % above |
| EV/EBIT | — | 24,1 · n=103 | — |
| Free-cash-flow yield | 4,4 % | 2,8 % · n=187 | 58 % above |
| Dividend yield | 2,31 % | 0,00 % · n=215 | — |
| Return on equity | 7,0 % | 2,7 % · n=193 | 163 % above |
| Return on invested capital | — | 3,5 % · n=176 | — |
| Gross margin | 73,0 % | 62,5 % · n=152 | 17 % above |
| Net debt / EBITDA | — | 1,19 · n=108 | — |
Value factor: 50 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| Instrument | P/E | P/B | EV/EBIT | Free-cash-flow yield | Dividend yield | Smart Score |
|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | 42,6 | 33,6 | — | 1,6 % | 0,6 % | 6/10 |
| JNJJohnson & Johnson | 29,1 | 7,2 | — | 3,6 % | 2,1 % | 8/10 |
| ABBVAbbVie | 79,9 | — | 33,5 | 3,6 % | 3,0 % | 5/10 |
| UNHUnitedHealth | 25,1 | 3,4 | 18,6 | 6,7 % | 2,3 % | 9/10 |
| TMOThermo Fisher Scientific | 35,7 | 4,7 | 35,2 | 2,9 % | 0,3 % | 8/10 |
| AMGNAmgen | 26,3 | 19,7 | 24,0 | 4,4 % | 2,3 % | 6/10 |
| GILDGILEAD | — | 16,1 | — | 6,8 % | 2,1 % | 4/10 |
| ABTAbbott | 28,5 | 3,4 | 26,8 | 4,1 % | 3,0 % | 5/10 |
| PFEPfizer | 38,4 | 2,0 | — | 6,6 % | 5,9 % | 1/10 |
| DHRDanaher | 39,4 | 3,0 | 35,1 | 3,5 % | 0,7 % | 5/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Juni 2026 · filed 07 Aug. 2026
Hier aus Vertrag aussteigen · EU-Verbraucher: 14 Tage Widerrufsrecht bei Käufen.